SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193805-24-000551
Filing Date
2024-04-23
Accepted
2024-04-23 16:48:40
Documents
7
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 e663535_def14a-immunic.htm DEF 14A 390494
2 GRAPHIC image_004.jpg GRAPHIC 6573
3 GRAPHIC image_001.jpg GRAPHIC 50806
4 GRAPHIC image_002.jpg GRAPHIC 48588
5 GRAPHIC image_003.jpg GRAPHIC 788
6 GRAPHIC image_005.jpg GRAPHIC 746
7 GRAPHIC image_006.jpg GRAPHIC 631
  Complete submission text file 0001193805-24-000551.txt   541374
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36201 | Film No.: 24865460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)